MMPI Investment Report 2021 Q4


2021 was another very exciting year for MMPI’s investment products, with 17 maturities posting average returns of 109.00%, (ranging from 104% to 116%). These represent extremely attractive pay-outs given that deposit rates are close to zero (maybe even minus for some consumers) and government bonds have been producing negative returns for some time.

2022 has gotten off to a great start with the MMPI Escalator Plan Series 59B producing a return of 116.88% after 30 months – and MMPI is hopeful of many more positive performances throughout the year with another 15 products having observation dates this year.

In 2021 Q4, the MMPI Escalator Plan Series 68 produced an excellent gross return of +106.00% after 12 months; while Series 69 offered up a return of +104.24% in its first year.

It remains the case that just 7 of MMPI’s investment products out of a total of 108 maturities in its Escalator and Protector series, stretching back over 12 years, have returned less than 100% of the initial capital invested. This is impressive given the level of risk/reward involved.

MMPI recognises that capital security is very important for most retail investors. In all of the cases cited above, the capital protection was provided by BNP Paribas, or Goldman Sachs International two of Europe’s most capitalised banks. Both currently has a top-quality credit grade and a stable rating – well ahead of Irish and UK banks.

MMPI realises that the Escalator suite of products is not suitable for everybody. However, the investments do potentially represent a wonderful opportunity to beat deposit returns. There are additional investment risks associated with the Escalator products and these need to be borne in mind and understood.

As always, MMPI recommends that potential investors read the Key Information Documents and the Product Brochures where a full list of WARNINGS is provided. Specific professional advice, offered by MMPI in private consultation, should always be sought in relation to individual circumstances.

MMPI will continue to take soundings from investors as to their investment preferences. To-date investors have been most concerned about receiving a decent return in such a low interest-rate environment. Many have come to the realisation that deposit rates are not keeping pace with inflation; and will fall further behind in the coming years.

Investors are also anxious about access to funds in case of emergency or where personal circumstances take an unexpected turn. Investments in the MMPI Escalator Series carry a nominal 5-year term but each investment contains daily liquidity. This means that funds may be redeemed at any time during the term. Some early redemptions may mean that investors will not get back all of the money invested but there are plenty of examples where redeeming investors receive back 100% of their initial investment plus additional positive growth.

For further details on any aspect of MMPI’s suite of products and services, please call the office on (01) 66 88 322 or e-mail Full details are also available on our website:-

error: Content is protected !!